Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Cilastatin Intermediate. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN102757924A details a novel Rhodococcus strain for high-purity (S)-(+)-DMCPA production, offering superior enantioselectivity and scalable manufacturing for cilastatin synthesis.
Patent CN102161978B reveals a green Rhodococcus strain for Cilastatin intermediates. Achieve high optical purity with reduced environmental impact and lower manufacturing costs.
Patent CN104193645A reveals efficient asymmetric synthesis. Delivers >99.5% ee. Ideal for Cilastatin production. Cost-effective supply chain solution for global buyers.
Patent CN1786179A details a novel dual-enzyme biocatalytic route for S-(+)-2,2-dimethylcyclopropylcarboxamide, offering superior stereocontrol and reduced environmental impact for cilastatin synthesis.